Logo

Abgenix, Agilent in Microarray Deal

Jul 08, 2002

NEW YORK, July 8-Abgenix will use Agilent's custom microarray platform, Agilent said today.

 

Abgenix researchers will have access to Agilent's microarray design services, custom oligo microarrays, microarray scanner, and the Rosetta software analysis system.

 

The companies did not disclose the financial specifics of the deal.

 

Abgenix focuses on developing and commercializing human antibodies for therapeutic use.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.